• Eton Pharmaceuticals director Charles J. Casamento sold 80,555 common shares on Nov. 10, 2026.
• Weighted average sale prices ranged from $64.3287 to $67.8695 per share.
• He exercised stock options to acquire 80,555 common shares the same day.
• Following the transactions, Casamento held no common shares directly; 29,000 stock options remained.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-036250), on November 10, 2026, and is solely responsible for the information contained therein.